Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Goodnick

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Psychiatry|January 1, 1993
Psychotropic treatment of chronic fatigue syndrome and related disordersP J Goodnick, R Sandoval
Expert Opinion on Pharmacotherapy|February 5, 2002
Antipsychotic medication: effects on regulation of glucose and lipidsM M Kato, P J Goodnick
Expert Opinion on Pharmacotherapy|May 5, 2001
Use of olanzapine in non-psychotic psychiatric disordersP J Goodnick, C A Barrios
Pharmacotherapy|November 1, 1995
Adverse events after the abrupt discontinuation of paroxetineR A Dominguez, P J Goodnick
Biological Psychiatry|May 20, 2000
Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depressionP J Goodnick, A M Kumar
Journal of Psychopharmacology (Oxford, England)|November 10, 1998
Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacologyP J Goodnick, B J Goldstein
Journal of Clinical Psychopharmacology|August 1, 1983
Effect of subchronic lithium treatment on apomorphine-induced change in prolactin and growth hormone secretionP J Goodnick, H Y Meltzer
Journal of Psychopharmacology (Oxford, England)|November 10, 1998
Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomicsB J Goldstein, P J Goodnick
The American Journal of Psychiatry|June 1, 1985
Plasma lithium level and interepisode functioning in bipolar disorderP J Goodnick, R R Fieve
The American Journal of Psychiatry|May 18, 1999
Treatment of chronic fatigue syndrome with nefazodoneP J Goodnick, C M Jorge
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Psychiatry|January 1, 1993
Psychotropic treatment of chronic fatigue syndrome and related disordersP J Goodnick, R Sandoval
Expert Opinion on Pharmacotherapy|February 5, 2002
Antipsychotic medication: effects on regulation of glucose and lipidsM M Kato, P J Goodnick
Expert Opinion on Pharmacotherapy|May 5, 2001
Use of olanzapine in non-psychotic psychiatric disordersP J Goodnick, C A Barrios
Pharmacotherapy|November 1, 1995
Adverse events after the abrupt discontinuation of paroxetineR A Dominguez, P J Goodnick
Biological Psychiatry|May 20, 2000
Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depressionP J Goodnick, A M Kumar
Journal of Psychopharmacology (Oxford, England)|November 10, 1998
Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacologyP J Goodnick, B J Goldstein
Journal of Clinical Psychopharmacology|August 1, 1983
Effect of subchronic lithium treatment on apomorphine-induced change in prolactin and growth hormone secretionP J Goodnick, H Y Meltzer
Journal of Psychopharmacology (Oxford, England)|November 10, 1998
Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomicsB J Goldstein, P J Goodnick
The American Journal of Psychiatry|June 1, 1985
Plasma lithium level and interepisode functioning in bipolar disorderP J Goodnick, R R Fieve
The American Journal of Psychiatry|May 18, 1999
Treatment of chronic fatigue syndrome with nefazodoneP J Goodnick, C M Jorge
Pageof 7